Overview / Abstract: |
Target Audience The intended audience for this activity is nurse practitioners and other health care professionals involved in the management of patients with influenza. Program Overview Although the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. With COVID-19 complicating influenza management, health care providers need better strategies for preventing, diagnosing, and treating influenza. Antivirals with different targets and mechanisms of action provide multiple therapeutic options and hold promise for improving treatment effectiveness. Influenza prophylaxis is also a very important component of management, yet providers are not adequately educated about it. In this continuing education activity, expert clinicians will discuss optimal ways to diagnose and manage influenza during the end stages of the COVID-19 pandemic. Learning Objectives Upon completion of this activity, participants should be better able to: |
Expiration |
Sep 29, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Format |
Online |
Credits / Hours |
0.75 Contact Hours |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Activity Co-Chairs FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Genentech, a member of the Roche Group. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Influenza Free CE CME |